Literature DB >> 2983944

Envelope properties of human T-cell leukemia viruses.

R A Weiss, P Clapham, K Nagy, H Hoshino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2983944     DOI： 10.1007/978-3-642-70113-9_15

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  21 in total

1.  Sequence variability of Borna disease virus: resistance to superinfection may contribute to high genome stability in persistently infected cells.

Authors:  S Formella; C Jehle; C Sauder; P Staeheli; M Schwemmle
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Characterization of new syncytium-inhibiting monoclonal antibodies implicates lipid rafts in human T-cell leukemia virus type 1 syncytium formation.

Authors:  K Niyogi; J E Hildreth
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.

Authors:  Ayse Kubra Coskun; Richard E Sutton
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 4.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

5.  Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes.

Authors:  G C Newbound; J M Andrews; J P O'Rourke; J N Brady; M D Lairmore
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Stimulation of virus production and induction of self-syncytium formation in human T-cell leukemia virus type I- and type II-infected T cells by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  M Wolfson; M Lev; I Avinoah; Z Malik; M Löchelt; R M Flügel; A Dombrovski; M Aboud
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Authors:  Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.

Authors:  Y Sagara; Y Inoue; H Shiraki; A Jinno; H Hoshino; Y Maeda
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.

Authors:  M G Agadjanyan; K E Ugen; B Wang; W V Williams; D B Weiner
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.

Authors:  K Fukudome; M Furuse; T Imai; M Nishimura; S Takagi; Y Hinuma; O Yoshie
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.